Countries Australia
See-Mode Technologies Receives FDA Clearance for AI-Powered Thyroid Ultrasound Analysis Software
See-Mode Technologies, a global innovator in AI for ultrasound imaging, announced the receipt of 510(k) clearance from the U.S. Food and Drug Administ...
September 18, 2024 | News
Genea Biomedx Joins Basecare Medical to Drive Global Expansion of Assisted Reproductive Technology
Genea Biomedx, which was once part of Genea Fertility, joined the Basecare Medical group in 2023 with the aim of distributing Basecare's assisted reproduct...
September 13, 2024 | News
Australia Faces Urgent Call to Address Childhood Dementia Crisis in New 2024 Report
A groundbreaking new report, "State of Childhood Dementia in Australia 2024," released at Australia's Parliament House in Ca...
September 10, 2024 | Report
Innovent Biologics Receives FDA Fast Track Designation for PD-1/IL-2α Bispecific Antibody in Advanced Melanoma Treatment
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...
September 04, 2024 | News
Telix Pharmaceuticals Submits NDA to FDA for Innovative Brain Cancer Imaging Agent Pixclara®
Telix Pharmaceuticals announces it has submitted a New Drug Application (NDA) to the United States (U.S.) Food and Drug Administration (FDA) for ...
August 28, 2024 | News
GE HealthCare and Roche Diagnostics Partner to Transform Precision Cancer Care in Asia Pacific
GE HealthCare and Roche Diagnostics have entered into a Memorandum of Understanding (MOU) that will leverage the strengths and resources of both comp...
August 22, 2024 | News
STADA Expands APAC Consumer Healthcare Portfolio with Acquisition of Nizoral Cream from Janssen
well as the trademark rights (TM) in Hong Kong, Australia, Indonesia, Malaysia, New Zealand and Singapore This transaction continues the successful acqu...
August 21, 2024 | News
STADA Expands APAC Consumer Healthcare Portfolio with Acquisition of Nizoral Cream from Janssen
well as the trademark rights (TM) in Hong Kong, Australia, Indonesia, Malaysia, New Zealand and Singapore This transaction continues the successful acqu...
August 20, 2024 | News
Noxopharm Targets First-in-Human Clinical Trial for First-in-Class Drug SOF-SKN™
Highlights: First-in-human clinical trial for SOF-SKN™ and Sofra™ platform Efficient trial design with early results expected Le...
August 19, 2024 | News
Propanc Biopharma Secures Canadian Patent for PRP Proenzyme Composition, Strengthening Global IP Portfolio
-Propanc Biopharma, Inc. a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer,&n...
August 16, 2024 | News
Alfred Health Expands Oracle EHR to Enhance Cancer Care and Clinical Trial Access
Leading Victorian healthcare network, Alfred Health, has extended its long-standing Oracle Health footprint with Oracle's Oncology electroni...
August 14, 2024 | News
Proto Axiom Secures $20M in Series B to Strengthen Australia's Biotech IP Retention
Proto Axiom, the Australian biomedical technology incubator has today announced a $20 million first close of its targeted $30 million S...
August 13, 2024 | News
Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
· Melbourne manufacturing site to be one of the most advanced pharmaceutical production facilities in Austr...
August 06, 2024 | News
ExoFlare Launches Pioneering Biosecurity Threat Management System Amid Avian Influenza Threat
With highly pathogenic avian influenza expected to hit our shores in as little as six weeks, a real time biosecurity threat management system will be ...
August 01, 2024 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
